Материал: part17

Скачать

Заказать новую работу

Внимание! Если размещение файла нарушает Ваши авторские права, то обязательно сообщите нам

Page 326​

DICOM PS3.17 2020a - Explanatory Information​

Contrast/Bolus Module Attribute​

Tag​

Product Characteristics Module Source​

Name​

 

 

Contrast/Bolus Total Dose​

(0018,1044)​

If contrast is administered using full contents of dispensed product:​

 

 

Product Parameter Sequence (0044,0013) > Numeric Value​

 

 

(0040,A30A), where:​

 

 

Product Parameter Sequence > Concept Name Code Sequence​

 

 

(0040,A043) value is (118565006, SCT, "Volume")​

 

 

Product Parameter Sequence > Measurement Units Code​

 

 

Sequence (0040,08EA) is (ml, UCUM, "ml")​

Contrast Flow Rate​

(0018,1046)​

 

Contrast Flow Duration​

(0018,1047)​

 

Contrast/Bolus Ingredient​

(0018,1048)​

Product Parameter Sequence (0044,0013) > Concept Code​

 

 

Sequence (0040,A168) > Code Meaning (0008,0104), where:​

 

 

Product Parameter Sequence > Concept Name Code Sequence​

 

 

(0040,A043) value is (127489000, SCT, "Active Ingredient")​

 

 

Note​

 

 

Contrast/Bolus Ingredient is a CS VR (16 characters max,​

 

 

upper case), so a conversion from the LO VR is required.​

Contrast/Bolus Ingredient​

(0018,1049)​

If contrast is administered without dilution:​

Concentration​

 

Product Parameter Sequence (0044,0013) > Numeric Value​

 

 

 

 

(0040,A30A), where:​

Product Parameter Sequence > Concept Name Code Sequence​ (0040,A043)valueis(121380,DCM,"ActiveIngredientUndiluted​ Concentration")​

Product Parameter Sequence > Measurement Units Code​

Sequence (0040,08EA) is (mg/ml, UCUM, "mg/ml")​

II.2 Enhanced Contrast/bolus Module​

Table II-2. Enhanced Contrast/Bolus Module Attribute Mapping​

Enhanced Contrast/Bolus Module​

Tag​

Product Characteristics Module Source​

Attribute Name​

 

 

Contrast/Bolus Agent Sequence​

(0018,0012)​

--​

>IncludeTable8.8-1“CodeSequenceMacroAttributes”inPS3.3​Product Type Code Sequence (0044,0007) > 'Code Sequence​

 

 

Macro'​

>Contrast/Bolus Agent Number​

(0018,9337)​

 

>Contrast/BolusAdministrationRoute​

(0018,0014)​

 

Sequence​

 

 

>>IncludeTable8.8-1“CodeSequenceMacroAttributes”inPS3.3​

>Contrast/Bolus Ingredient Code​

(0018,9338)​

--​

Sequence​

 

 

- Standard -​

 

DICOM PS3.17 2020a - Explanatory Information​

Page 327​

Enhanced Contrast/Bolus Module​

Tag​

Product Characteristics Module Source​

 

Attribute Name​

 

 

 

>>IncludeTable8.8-1“CodeSequenceMacroAttributes”inPS3.3​Product Parameter Sequence (0044,0013) > Concept Code​

 

 

Sequence (0040,A168), where:​

 

 

ProductParameterSequence>ConceptNameCodeSequence​

 

 

(0040,A043) value is (127489000, SCT, "Active Ingredient")​

>Contrast/Bolus Volume​

(0018,1041)​

If contrast is administered without dilution, and using full contents​

 

 

of dispensed product:​

 

 

Product Parameter Sequence (0044,0013) > Numeric Value​

 

 

(0040,A30A), where:​

 

 

ProductParameterSequence>ConceptNameCodeSequence​

 

 

(0040,A043) value is (118565006, SCT, "Volume")​

 

 

Product Parameter Sequence > Measurement Units Code​

 

 

Sequence (0040,08EA) is (ml, UCUM, "ml")​

>Contrast/Bolus Ingredient​

(0018,1049)​

If contrast is administered without dilution:​

Concentration​

 

Product Parameter Sequence (0044,0013) > Numeric Value​

 

 

 

 

(0040,A30A), where:​

 

 

ProductParameterSequence>ConceptNameCodeSequence​

 

 

(0040,A043)valueis(121380,DCM,"ActiveIngredientUndiluted​

 

 

Concentration")​

 

 

Product Parameter Sequence > Measurement Units Code​

 

 

Sequence (0040,08EA) is (mg/ml, UCUM, "mg/ml")​

>Contrast/Bolus Ingredient Opaque​

(0018,9425)​

Product Parameter Sequence (0044,0013) > Concept Code​

 

 

Sequence (0040,A168) > Code Meaning (0008,0104), where:​

 

 

ProductParameterSequence>ConceptNameCodeSequence​

 

 

(0040,A043) value is (121381, DCM, "Contrast/Bolus Ingredient​

 

 

Opaque") and mapped Code Meaning is "YES" or "NO".​

>Contrast Administration Profile​

(0018,9340)​

 

Sequence​

 

 

>>Contrast/Bolus Volume​

(0018,1041)​

If contrast is administered without dilution, and using full contents​

 

 

of dispensed product:​

 

 

Product Parameter Sequence (0044,0013) > Numeric Value​

 

 

(0040,A30A), where:​

 

 

ProductParameterSequence>ConceptNameCodeSequence​

 

 

(0040,A043) value is (118565006, SCT, "Volume")​

 

 

Product Parameter Sequence > Measurement Units Code​

 

 

Sequence (0040,08EA) is (ml, UCUM, "ml")​

>>Contrast/Bolus Start Time​

(0018,1042)​

 

>>Contrast/Bolus Stop Time​

(0018,1043)​

 

>>Contrast Flow Rate​

(0018,1046)​

 

>>Contrast Flow Duration​

(0018,1047)​

 

- Standard -​

Page 328​ DICOM PS3.17 2020a - Explanatory Information​

II.3 Device Module​

Table II-3. Device Module Attribute Mapping​

Device Module Attribute​

Tag​

Product Characteristics Module Source​

Name​

 

 

Device Sequence​

(0050,0010)​

--​

>Include Table 8.8-1 “Code Sequence Macro​ Product Type Code Sequence (0044,0007) > 'Code Sequence Macro'​

Attributes” in PS3.3​

 

 

>Device Length​

(0050,0014)​ ProductParameterSequence(0044,0013)>NumericValue(0040,A30A),where:​

 

 

Product Parameter Sequence > Concept Name Code Sequence (0040,A043)​

 

 

value is (410668003, SCT, "Length")​

 

 

Product Parameter Sequence > Measurement Units Code Sequence​

 

 

(0040,08EA) is (mm, UCUM, "mm")​

>Device Diameter​

(0050,0016)​ ProductParameterSequence(0044,0013)>NumericValue(0040,A30A),where:​

 

 

Product Parameter Sequence > Concept Name Code Sequence (0040,A043)​

 

 

value is (81827009, SCT, "Diameter")​

>Device Diameter Units​

(0050,0017)​ ProductParameterSequence(0044,0013)>MeasurementUnitsCodeSequence​

 

 

(0040,08EA) > Code Meaning (0008,0104), where:​

 

 

Product Parameter Sequence > Concept Name Code Sequence (0040,A043)​

 

 

value is (81827009, SCT, "Diameter")​

 

 

Note​

 

 

Device Diameter Units is a CS VR (16 characters max, upper case), so​

 

 

a conversion from the LO VR is required.​

>Device Volume​

(0050,0018)​ ProductParameterSequence(0044,0013)>NumericValue(0040,A30A),where:​

 

 

Product Parameter Sequence > Concept Name Code Sequence (0040,A043)​

 

 

value is (118565006, SCT, "Volume")​

 

 

Product Parameter Sequence > Measurement Units Code Sequence​

 

 

(0040,08EA) is (ml, UCUM, "ml")​

>Inter-Marker Distance​

(0050,0019)​ ProductParameterSequence(0044,0013)>NumericValue(0040,A30A),where:​

 

 

Product Parameter Sequence > Concept Name Code Sequence (0040,A043)​

 

 

value is (121208, DCM, "Inter-Marker Distance")​

 

 

Product Parameter Sequence > Measurement Units Code Sequence​

 

 

(0040,08EA) is (mm, UCUM, "mm")​

>Device Description​

(0050,0020)​ Product Name (0044,0008) and/or Product Description (0044,0009)​

II.4 Intervention Module​

Table II-4. Intervention Module Attribute Mapping​

Intervention Module Attribute Name​

Tag​

Product Characteristics​

 

 

Module Source​

Intervention Sequence​

(0018,0036)​

 

>Include Table 8.8-1 “Code Sequence Macro Attributes” in PS3.3​

 

 

- Standard -​

DICOM PS3.17 2020a - Explanatory Information​

Page 329​

Intervention Module Attribute Name​

Tag​

Product Characteristics​

 

 

Module Source​

>Intervention Status​

(0018,0038)​

 

>Intervention Drug Code Sequence​

(0018,0029)​

--​

>>Include Table 8.8-1 “Code Sequence Macro Attributes” in PS3.3​

 

Product Type Code Sequence​

 

 

(0044,0007) > 'Code Sequence​

 

 

Macro'​

>Intervention Drug Start Time​

(0018,0035)​

 

>Intervention Drug Stop Time​

(0018,0027)​

 

> Administration Route Code Sequence​

(0054,0302)​

 

>>Include Table 8.8-1 “Code Sequence Macro Attributes” in PS3.3​

 

 

>Intervention Description​

(0018,003A)​

 

- Standard -​

Page 330​

DICOM PS3.17 2020a - Explanatory Information​

- Standard -​

Источник: https://studfile.net/preview/14585770/

Смотрите также:

_1966(~1
_files_materials_5053_prog.ntr
_Антонян Ю.М., Сексуальные преступления. Чикатило и другие
_РГР № 1 (2)
- Габариты и масса 27
!Фармакология препаратов для терапии заболеваний дыхательных путей
'Исламское государство': причины возникновения, тенденции развития, технологии противостояния